Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Fujisawa, AtheroGenics to jointly develop transplant rejection treatment AGI-1096

Jan. 20, 2004

CP-690550 demonstrates immunosuppressive potential in mice

Jan. 20, 2004

Vertex claims JAK/CDK2 inhibitors for allergic and immune disorders

Jan. 20, 2004

Salix launches Azasan

Jan. 16, 2004

Significant improvements reported for tacrolimus ointment in cutaneous lupus erythematosus

Jan. 15, 2004

An anti-IL-5 antibody found safe and effective in patients with HES

Jan. 14, 2004

CYT-99-007 enters phase I

Jan. 14, 2004

Attenuated inflammatory response to sepsis found with N-acetylcysteine

Jan. 12, 2004

AMD-3100 induces the mobilization of hematopoietic progenitor cells in healthy volunteers

Jan. 8, 2004

JNJ-10329670 represents a new class of immunosuppressive compounds

Dec. 30, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 9, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
GDE4 blockade promotes remyelination, study finds
BioWorld Science
Myelin is crucial for the correct functioning of nerve signaling and its loss is a feature of neurological disorders. The cells responsible for myelination in the...